DAHUA-TECHNOLOGY
10.8.2021 15:47:09 CEST | Business Wire | Press release
Dahua Technology, a world leading video-centric smart IoT solution and service provider, has recently released its upgraded Full-color 2.0 Network Cameras that offer brand new functions – including Dual-lens, 4K Color Image, Vari-focal Lens, and AI Features – that can significantly optimize surveillance monitoring and greatly benefit end users in terms of clear and colorful image output.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210810005584/en/
Dual-lens Camera
The upgraded Full-color 2.0 offers dual-lens cameras with large F1.0 aperture, and Dual Light Fusion technology that collects visible color details and lightness information using separate lenses. Equipped with dual CMOS (1/1.8” and 1/2.8”), these cameras provide 36% increase in brightness and 14 times increase in s/n ratio. With pixel-level frame-by-frame mapping, they present high image definition and vivid colors even when the supplementary white light is off, thus reducing light pollution and attraction of insects. Also, its high precision AA (Active Alignment) process ensures that the lenses and sensors are all precisely aligned, allowing it to capture clear color images.
4K Color Image
The 4K network cameras of Full-color 2.0 are equipped with 1/1.2” image sensor. Compared with conventional 8MP camera, this image sensor significantly increases the pixel size by 110%, allowing it to capture real-time 4K color images even under low-light condition. These cameras also boast 42% increase in brightness, and 400% increase in S/N Ratio, providing a clear and high-quality image of the monitored scene.
Vari-focal Lens
The Full-color 2.0 cameras with vari-focal lens offer approx. 5x optical zoom and auto focus function that can maintain clear details even after zooming in. It solves the difficulty in capturing vivid color details of targets during night time or in environments with low illumination, which is a common pain point when using traditional IR vari-focal cameras. It covers narrow indoor spaces and wide outdoor scenarios, which can help ease operation and save time and labor costs.
AI Features
The upgraded Full-color 2.0 network cameras can work with Dahua 5-I/L series NVR, which enables color search for human and vehicle targets (person’s clothes and car exterior) and allows extraction of relevant video footages. It also offers AI Schedule that allows users to set different AI functions according to the time schedule.
By releasing its upgraded Full-color 2.0 Network Cameras, Dahua Technology delivers another artillery of new technologies that can enhance conventional monitoring and meet the various requirements of its customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210810005584/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Align Partners Issues Public Shareholder Letter and Submits Formal Shareholder Proposals to DB Insurance9.2.2026 15:26:00 CET | Press release
Align Partners underscores DBI’s persistent undervaluation (0.40x Adjusted PBR), despite industry-leading profitability, identifying inefficient capital allocation and governance issues as primary driversAlign Partners outlines measures for capital efficiency and governance normalization; requests a revised “Value-up” plan and a formal response from the Board by March 6, 2026The proposals nominate two Independent Directors via separate election and calls for the reinstatement of the Internal Transaction Committee Align Partners Capital Management Inc. (“Align Partners”), a shareholder of DB Insurance Co., Ltd. (KRX:005830) (“DBI” or the “Company”) holding 1.9%, has issued a public shareholder letter to DBI’s Board of Directors aimed at strengthening capital allocation policy and governance oversight, and submitted formal shareholder proposals for the 2026 Annual General Meeting (“AGM”). Despite DBI’s robust fundamentals—including a 16.1% ROE and a 226% K-ICS ratio—the Company trades at
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 13:00:00 CET | Press release
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 13:00:00 CET | Press release
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V
HKTDC to Host World’s Largest One-Stop Jewellery Marketplace9.2.2026 11:37:00 CET | Press release
New Hard Pure Gold Pavilion showcases breakthrough gold technologies Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one‑stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld‑Expo, featuring a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre, showcasing finished jewellery pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207153040/en/ Hong Kong International Jewellery Show and Hong Kong International Diamond, Gem & Pearl Show Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with nearly 70% coming
FlexTrade Integrates CME Group’s FX Spot+ and EBS Market Offerings for Enhanced FX Trading9.2.2026 11:30:00 CET | Press release
The initiative will see FlexTrade FX clients seamlessly access CME Group’s primary FX markets within FlexFX. FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group’s EBS Market central limit order book (CLOB) and its FX Spot+ platform.The move is designed to diversify and deepen the sources of actionable liquidity available to FlexTrade’s FlexFX users through an integration into CME Group's substantial liquidity pools for spots via FX Spot+. Providing firm, anonymous liquidity and no last-look pricing, EBS Market is a venue for both large market participants in search of FX liquidity in an all-to-all CLOB, and for market-making banks hedging FX risk. FX Spot+ further enhances spot liquidity with Futures liquidity from CME Group. This partnership is integral in helping firms further expand FX liquidity and take advantage of global opportunity. Mutual clients of FlexTrade and CME Group can integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
